Business
AI summaryIpsen S.A. is a biopharmaceutical company that develops and commercializes medicines in oncology, rare disease, and neuroscience across North America, Europe, and internationally. Its products include Somatuline for neuroendocrine tumors and acromegaly, Dysport for muscular disorders and aesthetics, Decapeptyl for prostate cancer and other indications, Cabometyx for renal and other cancers, Onivyde for metastatic pancreatic cancer, and Bylvay for progressive familial intrahepatic cholestasis and cholestatic pruritus.
